Published • loading... • Updated
Latus Bio Announces $97 Million Series A Financing to Expand the Reach of Gene Therapy to Larger Populations
Summary by Hastings Tribune
4 Articles
4 Articles
Verdict HospitalReposted by 
Pharmaceutical Business review
Pharmaceutical Business reviewLatus Bio secures $97m in funding to boost gene therapy access
Latus Bio has closed a $97m Series A financing round to expand the reach of its gene therapies targeting wider patient groups.The post Latus Bio secures $97m in funding to boost gene therapy access appeared first on Hospital Management.
Coverage Details
Total News Sources4
Leaning Left0Leaning Right0Center2Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
